The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2T Cells

Immunity

Volumn 40, Issue 4, 2014, Pages 490-500

  Sandstrom, Andrew ^a   Peigné, Cassie Marie ^b,c,d   Léger, Alexandra ^b,c,d   Crooks, JamesE ^a   Konczak, Fabienne ^b,c,d   Gesnel, Marie Claude ^b,c,d   Breathnach, Richard ^b,c,d   Bonneville, Marc ^b,c,d   Scotet, Emmanuel ^b,c,d   Adams, Erin J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b INSERM   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BUTYROPHILIN 3A1 PROTEIN; PHOSPHOANTIGEN; PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; B30.2 DOMAIN; BINDING AFFINITY; BINDING SITE; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; GAIN OF FUNCTION MUTATION; HUMAN; HUMAN CELL; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN DOMAIN; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ANTIGENS; ANTIGENS, CD; CELLS, CULTURED; DIPHOSPHONATES; HUMANS; IMIDAZOLES; INTRACELLULAR SPACE; LYMPHOCYTE ACTIVATION; MUTATION; PROTEIN BINDING; PROTEIN ENGINEERING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RNA, SMALL INTERFERING; T-LYMPHOCYTES;

EID: 84899121545     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.03.003     Document Type: Article

References (41)

1. Adams P.D., Afonine P.V., Bunkóczi G., Chen V.B., Davis I.W., Echols N., Headd J.J., Hung L.W., Kapral G.J., Grosse-Kunstleve R.W., et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 2010, 66:213-221.
2. Andersen O.A., Schönfeld D.L., Toogood-Johnson I., Felicetti B., Albrecht C., Fryatt T., Whittaker M., Hallett D., Barker J. Cross-linking of protein crystals as an aid in the generation of binary protein-ligand crystal complexes, exemplified by the human PDE10a-papaverine structure. Acta Crystallogr. D Biol. Crystallogr. 2009, 65:872-874.
3. Baker N.A., Sept D., Joseph S., Holst M.J., McCammon J.A. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl. Acad. Sci. USA 2001, 98:10037-10041.
4. Boëdec A., Sicard H., Dessolin J., Herbette G., Ingoure S., Raymond C., Belmant C., Kraus J.L. Synthesis and biological activity of phosphonate analogues and geometric isomers of the highly potent phosphoantigen (E)-1-hydroxy-2-methylbut-2-enyl 4-diphosphate. J.Med. Chem. 2008, 51:1747-1754.
5. Bonneville M., Scotet E. Human Vgamma9Vdelta2 Tcells: promising new leads for immunotherapy of infections and tumors. Curr. Opin. Immunol. 2006, 18:539-546.
6. Bukowski J.F., Morita C.T., Tanaka Y., Bloom B.R., Brenner M.B., Band H. V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J.Immunol. 1995, 154:998-1006.
7. Chen Z.W. Multifunctional immune responses of HMBPP-specific Vγ2Vδ2 Tcells in M. tuberculosis and other infections. Cell. Mol. Immunol. 2013, 10:58-64.
8. Constant P., Davodeau F., Peyrat M.A., Poquet Y., Puzo G., Bonneville M., Fournié J.J. Stimulation of human gamma delta Tcells by nonpeptidic mycobacterial ligands. Science 1994, 264:267-270.
9. Davodeau F., Peyrat M.A., Hallet M.M., Gaschet J., Houde I., Vivien R., Vie H., Bonneville M. Close correlation between Daudi and mycobacterial antigen recognition by human gamma delta Tcells and expression of V9JPC1 gamma/V2DJC delta-encoded Tcell receptors. J.Immunol. 1993, 151:1214-1223.
10. Eberl M., Hintz M., Reichenberg A., Kollas A.K., Wiesner J., Jomaa H. Microbial isoprenoid biosynthesis and human gammadelta Tcell activation. FEBS Lett. 2003, 544:4-10.
11. Espinosa E., Belmant C., Pont F., Luciani B., Poupot R., Romagné F., Brailly H., Bonneville M., Fournié J.J. Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human gamma delta Tcells. J.Biol. Chem. 2001, 276:18337-18344.
12. Gober H.J., Kistowska M., Angman L., Jenö P., Mori L., De Libero G. Human Tcell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J.Exp. Med. 2003, 197:163-168.
13. Harly C., Guillaume Y., Nedellec S., Peigné C.M., Mönkkönen H., Mönkkönen J., Li J., Kuball J., Adams E.J., Netzer S., et al. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset. Blood 2012, 120:2269-2279.
14. Hintz M., Reichenberg A., Altincicek B., Bahr U., Gschwind R.M., Kollas A.K., Beck E., Wiesner J., Eberl M., Jomaa H. Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gammadelta Tcells in Escherichia coli. FEBS Lett. 2001, 509:317-322.
15. Julian R.R., Beauchamp J.L. Site specific sequestering and stabilization of charge in peptides by supramolecular adduct formation with 18-crown-6 ether by way of electrospray ionization. Int. J. Mass Spectrom. 2001, 210-211:613-623.
16. Keeble A.H., Khan Z., Forster A., James L.C. TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved. Proc. Natl. Acad. Sci. USA 2008, 105:6045-6050.
17. Kotlyar S.A., Zubatyuk R.I., Shishkin O.V., Chuprin G.N., Kiriyak A.V., Kamalov G.L. (18-Crown-6)potassium chlorochromate. Acta Crystallogr. Sect. E Struct. Rep. Online 2005, 61:m293-m295.
18. Kunzmann V., Bauer E., Wilhelm M. Gamma/delta T-cell stimulation by pamidronate. N.Engl. J. Med. 1999, 340:737-738.
19. Kunzmann V., Bauer E., Feurle J., Weissinger F., Tony H.P., Wilhelm M. Stimulation of gammadelta Tcells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 2000, 96:384-392.
20. Lang F., Peyrat M.A., Constant P., Davodeau F., David-Ameline J., Poquet Y., Vié H., Fournié J.J., Bonneville M. Early activation of human V gamma 9V delta 2 Tcell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. J.Immunol. 1995, 154:5986-5994.
21. Lusty C.J. A gentle vapor-diffusion technique for cross-linking of protein crystals for cryocrystallography. J.Appl. Cryst. 1999, 32:106-112.
22. McClanahan J., Fukushima P.I., Stetler-Stevenson M. Increased peripheral blood gamma delta T-cells in patients with lymphoid neoplasia: A diagnostic dilemma in flow cytometry. Cytometry 1999, 38:280-285.
23. McCoy A.J., Grosse-Kunstleve R.W., Adams P.D., Winn M.D., Storoni L.C., Read R.J. Phaser crystallographic software. J.Appl. Cryst. 2007, 40:658-674.
24. Morita C.T., Beckman E.M., Bukowski J.F., Tanaka Y., Band H., Bloom B.R., Golan D.E., Brenner M.B. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta Tcells. Immunity 1995, 3:495-507.
25. Morita C.T., Jin C., Sarikonda G., Wang H. Nonpeptide antigens,presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 Tcells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol. Rev. 2007, 215:59-76.
26. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997, 276:307-326.
27. Palakodeti A., Sandstrom A., Sundaresan L., Harly C., Nedellec S., Olive D., Scotet E., Bonneville M., Adams E.J. The molecular basis for modulation of human Vγ9Vδ2 Tcell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodies. J.Biol. Chem. 2012, 287:32780-32790.
28. Puan K.J., Jin C., Wang H., Sarikonda G., Raker A.M., Lee H.K., Samuelson M.I., Märker-Hermann E., Pasa-Tolic L., Nieves E., et al. Preferential recognition of a microbial metabolite by human Vgamma2Vdelta2 Tcells. Int. Immunol. 2007, 19:657-673.
29. Rhodes D.A., Stammers M., Malcherek G., Beck S., Trowsdale J. The cluster of BTN genes in the extended major histocompatibility complex. Genomics 2001, 71:351-362.
30. Tanaka Y., Sano S., Nieves E., De Libero G., Rosa D., Modlin R.L., Brenner M.B., Bloom B.R., Morita C.T. Nonpeptide ligands for human gamma delta Tcells. Proc. Natl. Acad. Sci. USA 1994, 91:8175-8179.
31. Tanaka Y., Morita C.T., Tanaka Y., Nieves E., Brenner M.B., Bloom B.R. Natural and synthetic non-peptide antigens recognized by human gamma delta Tcells. Nature 1995, 375:155-158.
32. Trott O., Olson A.J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J.Comput. Chem. 2010, 31:455-461.
33. Vavassori S., Kumar A., Wan G.S., Ramanjaneyulu G.S., Cavallari M., El Daker S., Beddoe T., Theodossis A., Williams N.K., Gostick E., et al. Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ Tcells. Nat. Immunol. 2013, 14:908-916.
34. Wang H., Lee H.K., Bukowski J.F., Li H., Mariuzza R.A., Chen Z.W., Nam K.H., Morita C.T. Conservation of nonpeptide antigen recognition by rhesus monkey V gamma 2V delta 2 Tcells. J.Immunol. 2003, 170:3696-3706.
35. Wang H., Fang Z., Morita C.T. Vgamma2Vdelta2T Cell Receptor recognition of prenyl pyrophosphates is dependent on all CDRs. J.Immunol. 2010, 184:6209-6222.
36. Wang H., Henry O., Distefano M.D., Wang Y.C., Räikkönen J., Mönkkönen J., Tanaka Y., Morita C.T. Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 Tcells. J.Immunol. 2013, 191:1029-1042.
37. Wei H., Huang D., Lai X., Chen M., Zhong W., Wang R., Chen Z.W. Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate to Vgamma2Vdelta 2 TCR. J.Immunol. 2008, 181:4798-4806.
38. Weinert C., Grütter C., Roschitzki-Voser H., Mittl P.R., Grütter M.G. The crystal structure of human pyrin b30.2 domain: implications for mutations associated with familial Mediterranean fever. J.Mol. Biol. 2009, 394:226-236.
39. Winn M.D., Ballard C.C., Cowtan K.D., Dodson E.J., Emsley P., Evans P.R., Keegan R.M., Krissinel E.B., Leslie A.G., McCoy A., et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. DBiol. Crystallogr. 2011, 67:235-242.
40. Woo J.S., Imm J.H., Min C.K., Kim K.J., Cha S.S., Oh B.H. Structural and functional insights into the B30.2/SPRY domain. EMBO J. 2006, 25:1353-1363.
41. Zhang Y., Song Y., Yin F., Broderick E., Siegel K., Goddard A., Nieves E., Pasa-Tolic L., Tanaka Y., Wang H., et al. Structural studies of Vgamma2Vdelta2 Tcell phosphoantigens. Chem. Biol. 2006, 13:985-992.